Zinzino Triples Down on Acquisitions, Rewards Shareholders with Dividend Hike
Event summary
- Zinzino reported full-year 2025 revenue of SEK 3.34 billion, a 51% increase year-over-year.
- The company’s EBITDA margin improved to 13.3% in 2025, up from 11.4% the previous year, driven by stronger gross profit and synergies from acquisitions.
- Zinzino acquired a 35% stake in Xion International Group to secure omega-3 supply and acquired the assets of Sanki to expand distribution in the Americas.
- The Board proposes a dividend of SEK 6.00 per share, a 50% increase from the previous year, totaling SEK 217.9 million.
- Following the reporting date, Zinzino acquired It Works! to bolster distribution in North America and Europe.
The big picture
Zinzino’s rapid growth and shareholder returns are fueled by a strategy of aggressive acquisitions and expansion into new markets. The company’s focus on direct sales and nutritional supplements places it within a competitive landscape, and its reliance on acquisitions carries integration risk. The move to secure omega-3 supply through Xion International Group signals a broader trend towards supply chain resilience within the health and wellness sector.
What we're watching
- Acquisition Integration
- The success of Zinzino’s aggressive acquisition strategy hinges on effectively integrating It Works! and Sanki, which could be challenging given the diverse business models.
- Sustainability
- The investment in Xion International Group to secure omega-3 supply demonstrates a focus on sustainability, but the viability of algae bioreactor production at scale remains to be seen.
- Distribution Scale
- Zinzino’s reliance on direct sales and acquisitions to drive growth exposes it to potential saturation and regulatory scrutiny in key markets.
Related topics